Last reviewed · How we verify
NCT07017205
Microaspiration and Endotracheal Tubes
NA trial testing Application of oropharyngeal dye and tracheal aspirate collection in Endotracheal Tube Cuff in 72 participants. Not yet recruiting.
30 April 2026
Quick facts
| Lead sponsor | Argentinian Intensive Care Society |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | screening |
| Enrollment | 72 |
| Start date | 1 February 2026 |
| Primary completion | 30 April 2026 |
| Estimated completion | 31 May 2026 |
| Sites | 1 location across Argentina |
Drugs / interventions tested
- Application of oropharyngeal dye and tracheal aspirate collection
Conditions studied
- Endotracheal Tube Cuff — all drugs for Endotracheal Tube Cuff →
- Microaspiration — all drugs for Microaspiration →
- Endotracheal Tube Cuff Pressure — all drugs for Endotracheal Tube Cuff Pressure →
Sponsor
Argentinian Intensive Care Society
Who can join
18 and older, any sex, with Endotracheal Tube Cuff or Microaspiration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if a new method for managing breathing tube pressure is better at preventing fluid from leaking into patients' lungs during surgery. It will also check if it causes fewer side effects like a sore throat. The main questions it aims to answer are: Does using a continuous pressure controller reduce fluid leakage past the breathing tube cuff compared to the standard manual method? Does the continuous pressure controller lead to fewer and less severe sore throats and voice changes after surgery? Researchers will compare two groups: Group 1: Patients whose breathing tube cuff pressure is managed with a continuous automatic controller. Group 2: Patients whose breathing tube cuff pressure is managed with the standard manual method. Participants will: Be randomly assigned to one of the two groups before their surgery. Receive a small, safe amount of blue dye in their mouth during the procedure to help measure leakage. Have two small secretion samples collected from their breathing tube during surgery. Be asked about sore throat and voice changes at 1, 2, 3, and 24 hours after the breathing tube is removed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07017205
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Argentinian Intensive Care Society trials
Trials by the same sponsor.
- NCT06837402 — Epidemiology of Non- Invasive Mechanical Ventilation in Argentina: a Multicenter Observational Study · enrolling by invitation
- NCT06824220 — Effect of High-Flow Tracheal Oxygen on EELI · NA · active not recruiting
- NCT06674629 — Asymmetrical High Flow Nasal Cannula and End-Expiratory Lung Impedance · completed
- NCT06662201 — Association Between P0.1 and Extubation Failure in Adult Patients With Acute Hypoxemic Respiratory Failure. A Multicente · active not recruiting
- NCT06536972 — Dual-focus Survey with an Emphasis on Heated Humidification Systems · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07017205 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Argentinian Intensive Care Society
- Last refreshed: 15 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07017205.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing